
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Signaling alterations caused by drugs and autophagy
Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Cellular Signalling (2019) Vol. 64, pp. 109416-109416
Closed Access | Times Cited: 20
Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Cellular Signalling (2019) Vol. 64, pp. 109416-109416
Closed Access | Times Cited: 20
Showing 20 citing articles:
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
Annamaria Colao, Filomena de Nigris, Roberta Modica, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 37
Annamaria Colao, Filomena de Nigris, Roberta Modica, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 37
Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling
Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 11, pp. 7889-7899
Open Access | Times Cited: 34
Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 11, pp. 7889-7899
Open Access | Times Cited: 34
The multi-kinase inhibitor lenvatinib interacts with the HDAC inhibitor entinostat to kill liver cancer cells
Jane L. Roberts, Andrew Poklepovic, Laurence Booth, et al.
Cellular Signalling (2020) Vol. 70, pp. 109573-109573
Closed Access | Times Cited: 27
Jane L. Roberts, Andrew Poklepovic, Laurence Booth, et al.
Cellular Signalling (2020) Vol. 70, pp. 109573-109573
Closed Access | Times Cited: 27
Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer
Laurence Booth, Andrew Poklepovic, Paul Dent
Biochemical Pharmacology (2020) Vol. 178, pp. 114067-114067
Open Access | Times Cited: 22
Laurence Booth, Andrew Poklepovic, Paul Dent
Biochemical Pharmacology (2020) Vol. 178, pp. 114067-114067
Open Access | Times Cited: 22
Cocaine-induced locomotor stimulation involves autophagic degradation of the dopamine transporter
Maged M. Harraz, Prasun Guha, In Guk Kang, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 2, pp. 370-382
Open Access | Times Cited: 20
Maged M. Harraz, Prasun Guha, In Guk Kang, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 2, pp. 370-382
Open Access | Times Cited: 20
New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges
Alessandro Allegra, Giovanni Pioggia, Vanessa Innao, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1981-1981
Open Access | Times Cited: 19
Alessandro Allegra, Giovanni Pioggia, Vanessa Innao, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1981-1981
Open Access | Times Cited: 19
The Tubulin Code and Tubulin-Modifying Enzymes in Autophagy and Cancer
Daniela Trisciuoglio, Francesca Degrassi
Cancers (2021) Vol. 14, Iss. 1, pp. 6-6
Open Access | Times Cited: 18
Daniela Trisciuoglio, Francesca Degrassi
Cancers (2021) Vol. 14, Iss. 1, pp. 6-6
Open Access | Times Cited: 18
Not the comfy chair! Cancer drugs that act against multiple active sites
Laurence Booth, Andrew Poklepovic, Paul Dent
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 11, pp. 893-901
Open Access | Times Cited: 16
Laurence Booth, Andrew Poklepovic, Paul Dent
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 11, pp. 893-901
Open Access | Times Cited: 16
Chronic cadmium exposure induces epithelial mesenchymal transition in prostate cancer cells through a TGF-β-independent, endoplasmic reticulum stress induced pathway
Weirong Hu, Mi‐Zhen Xia, Cheng Zhang, et al.
Toxicology Letters (2021) Vol. 353, pp. 107-117
Open Access | Times Cited: 14
Weirong Hu, Mi‐Zhen Xia, Cheng Zhang, et al.
Toxicology Letters (2021) Vol. 353, pp. 107-117
Open Access | Times Cited: 14
Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway
Lili Song, Shikai Liu, Sufen Zhao
Bioengineered (2022) Vol. 13, Iss. 4, pp. 11240-11257
Open Access | Times Cited: 10
Lili Song, Shikai Liu, Sufen Zhao
Bioengineered (2022) Vol. 13, Iss. 4, pp. 11240-11257
Open Access | Times Cited: 10
Endoplasmic Reticulum Stress-Related Signature Predicts Prognosis and Drug Response in Clear Cell Renal Cell Carcinoma
Yuke Zhang, Yancheng Song, Jiangwen Dai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Yuke Zhang, Yancheng Song, Jiangwen Dai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Endoplasmic reticulum stress caused by traumatic injury promotes cardiomyocyte apoptosis through acetylation modification of GRP78
Zi Yan, Yufeng Liu, Bowen Yang, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 56, Iss. 1, pp. 96-105
Open Access | Times Cited: 5
Zi Yan, Yufeng Liu, Bowen Yang, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 56, Iss. 1, pp. 96-105
Open Access | Times Cited: 5
Fingolimod Augments Monomethylfumarate Killing of GBM Cells
Paul Dent, Laurence Booth, Jane L. Roberts, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 10
Paul Dent, Laurence Booth, Jane L. Roberts, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 10
Enhanced signaling via ERBB3/PI3K plays a compensatory survival role in pancreatic tumor cells exposed to [neratinib + valproate]
Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Cellular Signalling (2020) Vol. 68, pp. 109525-109525
Open Access | Times Cited: 8
Paul Dent, Laurence Booth, Andrew Poklepovic, et al.
Cellular Signalling (2020) Vol. 68, pp. 109525-109525
Open Access | Times Cited: 8
Metabolism of Histone Deacetylase Proteins Opsonizes Tumor Cells to Checkpoint Inhibitory Immunotherapies
Paul Dent, Laurence Booth, Andrew Poklepovic
Immunometabolism (2019) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Paul Dent, Laurence Booth, Andrew Poklepovic
Immunometabolism (2019) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Inhibition of immunity control points in ovarian cancer
A.V. Asaturova, Anna Tregubova, D.V. Shushkanova
CLINICAL AND EXPERIMENTAL MORPHOLOGY (2020) Vol. 9, Iss. 1, pp. 11-19
Open Access | Times Cited: 2
A.V. Asaturova, Anna Tregubova, D.V. Shushkanova
CLINICAL AND EXPERIMENTAL MORPHOLOGY (2020) Vol. 9, Iss. 1, pp. 11-19
Open Access | Times Cited: 2
Cell Signaling and Translational Developmental Therapeutics
Paul Dent
Elsevier eBooks (2021)
Closed Access | Times Cited: 1
Paul Dent
Elsevier eBooks (2021)
Closed Access | Times Cited: 1
Kinase inhibitors: look beyond the label on the bottle
Paul Dent, Andrew Poklepovic, Laurence Booth, et al.
Cancer Drug Resistance (2019)
Open Access
Paul Dent, Andrew Poklepovic, Laurence Booth, et al.
Cancer Drug Resistance (2019)
Open Access
Cell Signaling and Translational Developmental Therapeutics
Paul Dent
Elsevier eBooks (2020), pp. 250-261
Closed Access
Paul Dent
Elsevier eBooks (2020), pp. 250-261
Closed Access